TY - GEN 
AU - Denton E.
AU - Hew M.
AU - Peters M.J.
AU - Upham J.W.
AU - Bulathsinhala L.
AU - Tran T.N.
AU - Martin N.
AU - Bergeron C.
AU - Al-Ahmad M.
AU - Altraja A.
AU - Larenas-Linnemann D.
AU - Murray R.
AU - Celis-Preciado C.A.
AU - Al-Lehebi R.
AU - Belhassen M.
AU - Bhutani M.
AU - Bosnic-Anticevich S.Z.
PY - 2024
SN - 1054538
UR - http://hdl.handle.net/10818/62730
AB - Background: Biologic asthma therapies reduce exacerbations and long-term oral corticosteroids (LTOCS) use in randomized controlled trials (RCTs); however, there are limited data on outcomes among patients ineligible for RCTs. Hence, we investigated...
LA - eng
PB - Allergy: European Journal of Allergy and Clinical Immunology
KW - Asthma
KW - Biologics
KW - Clinical Response
KW - Monoclonal antibodies
KW - Super-Responders
TI - Real-world biologics response and super-response in the International Severe Asthma Registry cohort
DO - 10.1111/all.16178
ER -